NASDAQ
9.40USD
+0.12 (+1.29%)
We have scored 68 news catalysts on Capricor Therapeutics, Inc. (CAPR) over the past 12 months. The biggest single-day move next to one of them came Aug 15, 2026, when CAPR closed +58.0%: “NASDAQ: CAPR: Kessler Topaz Meltzer & Check, LLP Announces the Filing of a Securities Fraud Class Action Lawsuit Against Capricor Therapeutics, Inc”. Coverage across the window leans negative (average ticker sentiment −0.61). Most of the impact sits in price momentum and forward growth expectations.
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Latest scored catalyst for CAPR: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Market cap
540.6M
P/E
—
EPS
—
Beta
0.53
52W range
2.96-40.37
Day range
9.26–9.81
Open
9.40
Prev close
9.28
Volume
2.6M
Avg volume
4.6M
Dividend
0.00
IPO
2007-02-13
Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about Capricor Therapeutics, Inc. — not a sector bucket. Click an edge to see the articles that established the link.
